HCV - Liver Cirrhosis
Sustained Virological Response to Interferon-based Therapy Slows Progression of Liver Cirrhosis in Hepatitis C Patients 11-24-09 Coffee Slows Progression of Liver Disease in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis 10-23-09 Hepatitis C May Not Increase Mortality among Patients Who Are Not Coinfected, Do Not Drink Heavily, and Do Not Have Cirrhosis 9-25-09 Bone Loss and Vitamin D Deficiency Are Common among People with Liver Cirrhosis 9-01-2009 Diets High in Protein and Cholesterol May Increase Risk of Liver Cirrhosis and Cancer, while Carbohydrates May Be Protective 8-7-2009 Pegylated Interferon alfa-2b (PegIntron) Maintenance Monotherapy May Reduce Esophageal Varices in Hepatitis C Patients with Cirrhosis 5-5-09 Liver Disease Progression and Treatment Response in Latino and Asian Patients with Chronic Hepatitis C 12-12-08 Selected Hepatitis C Patients with Decompensated Cirrhosis Can Benefit from Interferon-based Therapy prior to Liver Transplantation 6-10-08 Natural History of HCV-Related Cirrhosis after Liver Transplantation 5-08-08 Pegylated Interferon plus Ribavirin for Patients with HCV-related Liver Cirrhosis 3-11-08
Non-Invasive Ways to Assess Liver Disease: Studies Test Alternatives to Liver Biopsy 2-05-08
Cirrhosis Fibrosis Hepatocellular Carcinoma Liver Transplantation Liver Biopsy Steatosis Anemia Chilren / Infants / Women Drug Abuse Experimental Treatments FAQs About Hepatitis C Genotypes Insulin Resistance / Diabetes Sustained Viral Response (SVR) Tests for HCV Vaccines for HCV
